The Valley Desk

NCT03762850 · Interventional trial

A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

Overall registry status Completed

Phase 3

Conditions Immunoglobulin A Nephropathy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov